{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T20:22:56Z","timestamp":1784665376823,"version":"3.55.0"},"reference-count":55,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2018,1,31]],"date-time":"2018-01-31T00:00:00Z","timestamp":1517356800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"SANTHE","award":["DEL-15-006"],"award-info":[{"award-number":["DEL-15-006"]}]},{"name":"SANTHE","award":["DEL-15-006"],"award-info":[{"award-number":["DEL-15-006"]}]},{"name":"ACHAP"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0192030","type":"journal-article","created":{"date-parts":[[2018,1,31]],"date-time":"2018-01-31T13:50:35Z","timestamp":1517406635000},"page":"e0192030","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":12,"title":["Immunological non-response and low hemoglobin levels are predictors of incident tuberculosis among HIV-infected individuals on Truvada-based therapy in Botswana"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2290-2481","authenticated-orcid":true,"given":"Lucy","family":"Mupfumi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sikhulile","family":"Moyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kesaobaka","family":"Molebatsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prisca K.","family":"Thami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motswedi","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuelo","family":"Mogashoa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thato","family":"Iketleng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Makhema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ric","family":"Marlink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ishmael","family":"Kasvosve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"Essex","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosemary M.","family":"Musonda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simani","family":"Gaseitsiwe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,1,31]]},"reference":[{"key":"ref1"},{"issue":"6","key":"ref2","first-page":"502","article-title":"Tuberculosis control in South Africa\u2014will HAART help?","volume":"96","author":"SD Lawn","year":"2006","journal-title":"South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1097\/01.aids.0000238406.93249.cd","article-title":"Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis control","volume":"20","author":"D Stephen","year":"2006","journal-title":"AIDS"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1056\/NEJMoa0905848","article-title":"Timing of Initiation of Antiretroviral Drugs during Tuberculosis Therapy","volume":"362","author":"SS Abdool Karim","year":"2010","journal-title":"The New England journal of medicine"},{"issue":"9809","key":"ref5","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1016\/S0140-6736(11)61136-7","article-title":"Antiretroviral prophylaxis: a defining moment in HIV control","volume":"378","author":"SSA Karim","year":"2011","journal-title":"The Lancet"},{"issue":"9635","key":"ref6","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0140-6736(08)61101-0","article-title":"Monitoring of antiretroviral therapy in low-resource settings","volume":"372","author":"SD Lawn","year":"2008","journal-title":"Lancet"},{"issue":"15","key":"ref7","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1097\/QAD.0b013e32830007cd","article-title":"Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa","volume":"22","author":"SD Lawn","year":"2008","journal-title":"AIDS"},{"issue":"12","key":"ref8","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1097\/QAD.0b013e328348fb61","article-title":"Reducing tuberculosis-associated early mortality in antiretroviral treatment programmes in sub-Saharan Africa","volume":"25","author":"SD Lawn","year":"2011","journal-title":"AIDS"},{"key":"ref9","first-page":"175","article-title":"Undiagnosed tuberculosis in a community with high HIV prevalence: implications for tuberculosis control","author":"R Wood","year":"2007","journal-title":"American journal of respiratory and critical care medicine"},{"issue":"3","key":"ref10","doi-asserted-by":"crossref","first-page":"e34156","DOI":"10.1371\/journal.pone.0034156","article-title":"Tuberculosis Incidence Rates during 8 Years of Follow-Up of an Antiretroviral Treatment Cohort in South Africa: Comparison with Rates in the Community","volume":"7","author":"A Gupta","year":"2012","journal-title":"PloS one"},{"issue":"4","key":"ref11","doi-asserted-by":"crossref","first-page":"ofv154","DOI":"10.1093\/ofid\/ofv154","article-title":"Tuberculosis Incidence and Risk Factors Among Human Immunodeficiency Virus (HIV)-Infected Adults Receiving Antiretroviral Therapy in a Large HIV Program in Nigeria","volume":"2","author":"CA Chang","year":"2015","journal-title":"Open Forum Infect Dis"},{"issue":"6","key":"ref12","doi-asserted-by":"crossref","first-page":"e243","DOI":"10.1016\/S2352-3018(15)00063-6","article-title":"Does antiretroviral therapy reduce HIV-associated tuberculosis incidence to background rates? A national observational cohort study from England, Wales, and Northern Ireland","volume":"2","author":"RK Gupta","year":"2015","journal-title":"The Lancet HIV"},{"issue":"11","key":"ref13","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1086\/498030","article-title":"Efficacy of antiretroviral therapy in resource-poor settings: are outcomes comparable to those in the developed world?","volume":"41","author":"SD Lawn","year":"2005","journal-title":"Clinical infectious diseases: an official publication of the Infectious Diseases Society of America"},{"issue":"9","key":"ref14","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1093\/infdis\/jiw313","article-title":"Relationship Between HIV Coinfection, Interleukin 10 Production, and Mycobacterium tuberculosis in Human Lymph Node Granulomas","volume":"214","author":"CR Diedrich","year":"2016","journal-title":"The Journal of infectious diseases"},{"issue":"4","key":"ref15","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1128\/IAI.01126-10","article-title":"HIV-1\/Mycobacterium tuberculosis Coinfection Immunology: How Does HIV-1 Exacerbate Tuberculosis?","volume":"79","author":"CR Diedrich","year":"2011","journal-title":"Infection and immunity"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1186\/s12879-016-1598-8","article-title":"The incidence of tuberculosis among hiv-positive individuals with high CD4 counts: implications for policy","volume":"16","author":"T Kufa","year":"2016","journal-title":"BMC infectious diseases"},{"issue":"2","key":"ref17","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/QAI.0000000000001181","article-title":"Interleukin 1-Beta (IL-1beta) Production by Innate Cells Following TLR Stimulation Correlates With TB Recurrence in ART-Treated HIV-Infected Patients","volume":"74","author":"C Thobakgale","year":"2017","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"Suppl 1","key":"ref18","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/odi.12390","article-title":"HIV-TB co-infection: mechanisms that drive reactivation of Mycobacterium tuberculosis in HIV infection","volume":"22","author":"A Ahmed","year":"2016","journal-title":"Oral diseases"},{"issue":"11","key":"ref19","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1097\/QAD.0000000000000705","article-title":"Tuberculosis incidence rate and risk factors among HIV-infected adults with access to antiretroviral therapy in Tanzania","volume":"29","author":"E Liu","year":"2015","journal-title":"AIDS (London, England)"},{"issue":"18","key":"ref20","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1097\/01.aids.0000194808.20035.c1","article-title":"Tuberculosis among HIV-infected patients receiving HAART: long term incidence and risk factors in a South African cohort","volume":"19","author":"SD Lawn","year":"2005","journal-title":"AIDS"},{"issue":"8","key":"ref21","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.5588\/ijtld.15.0488","article-title":"Incident tuberculosis in HIV-positive children, adolescents and adults on antiretroviral therapy in South Africa","volume":"20","author":"AT Brennan","year":"2016","journal-title":"The International Journal of Tuberculosis and Lung Disease"},{"issue":"5","key":"ref22","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1093\/cid\/ciu945","article-title":"Complex Anemia in Tuberculosis: The Need to Consider Causes and Timing When Designing Interventions","volume":"60","author":"PA Minchella","year":"2015","journal-title":"Clinical Infectious Diseases"},{"issue":"10","key":"ref23","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1097\/QAD.0b013e32833a2a4a","article-title":"Body mass index and risk of tuberculosis and death","volume":"24","author":"CF Hanrahan","year":"2010","journal-title":"AIDS (London, England)"},{"issue":"4","key":"ref24","doi-asserted-by":"crossref","first-page":"e35948","DOI":"10.1371\/journal.pone.0035948","article-title":"Association of BMI Category Change with TB Treatment Mortality in HIV-Positive Smear-Negative and Extrapulmonary TB Patients in Myanmar and Zimbabwe","volume":"7","author":"L Benova","year":"2012","journal-title":"PloS one"},{"key":"ref25","first-page":"Cd003650","article-title":"Micronutrient supplementation in adults with HIV infection","volume":"5","author":"ME Visser","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"ref26","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-009058","article-title":"Determinants for tuberculosis in HIV-infected adults in Northwest Ethiopia: a multicentre case\u2013control study","volume":"6","author":"YM Alemu","year":"2016","journal-title":"BMJ open"},{"issue":"1","key":"ref27","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s11904-015-0256-x","article-title":"Persistent high mortality in advanced HIV\/TB despite appropriate antiretroviral and antitubercular therapy: an emerging challenge","volume":"12","author":"GP Bisson","year":"2015","journal-title":"Current HIV\/AIDS reports"},{"issue":"3","key":"ref28","doi-asserted-by":"crossref","first-page":"ofw140","DOI":"10.1093\/ofid\/ofw140","article-title":"Slow CD4+ T-Cell Recovery in Human Immunodeficiency Virus\/Hepatitis B Virus-Coinfected Patients Initiating Truvada-Based Combination Antiretroviral Therapy in Botswana","volume":"3","author":"M Anderson","year":"2016","journal-title":"Open Forum Infect Dis"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"670957","DOI":"10.1155\/2012\/670957","article-title":"Incomplete immune recovery in HIV infection: mechanisms, relevance for clinical care, and possible solutions","volume":"2012","author":"JC Gaardbo","year":"2012","journal-title":"Clinical & developmental immunology"},{"issue":"9","key":"ref30","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1093\/cid\/cis203","article-title":"Impact of antiretroviral therapy on tuberculosis incidence among HIV-positive patients in high-income countries","volume":"54","author":"J del Amo","year":"2012","journal-title":"Clinical infectious diseases: an official publication of the Infectious Diseases Society of America"},{"issue":"3","key":"ref31","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/QAI.0b013e31820413b3","article-title":"Antiretroviral therapy and TB notification rates in a high HIV prevalence South African community","volume":"56","author":"K Middelkoop","year":"2011","journal-title":"Journal of acquired immune deficiency syndromes (1999)"},{"issue":"12","key":"ref32","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1086\/498308","article-title":"Incidence of tuberculosis during highly active antiretroviral therapy in high-income and low-income countries","volume":"41","author":"SD Lawn","year":"2005","journal-title":"Clinical infectious diseases: an official publication of the Infectious Diseases Society of America"},{"key":"ref33","article-title":"Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis control","volume":"20","author":"SD Lawn","year":"2006","journal-title":"AIDS"},{"issue":"10","key":"ref34","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1164\/ajrccm.172.10.1348","article-title":"Risk factors for tuberculosis among HIV-infected patients receiving antiretroviral treatment","volume":"172","author":"SD Lawn","year":"2005","journal-title":"American journal of respiratory and critical care medicine"},{"issue":"13","key":"ref35","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1097\/QAD.0b013e32832d3b6d","article-title":"Short-term and long-term risk of tuberculosis associated with CD4 cell recovery during antiretroviral therapy in South Africa","volume":"23","author":"SD Lawn","year":"2009","journal-title":"Aids"},{"issue":"2","key":"ref36","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2165\/00003495-200868020-00004","article-title":"Immune reconstitution inflammatory syndrome in HIV-infected patients receiving antiretroviral therapy: pathogenesis, clinical manifestations and management","volume":"68","author":"DJ Dhasmana","year":"2008","journal-title":"Drugs"},{"issue":"11","key":"ref37","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1089\/aid.2009.0055","article-title":"Immunologic markers as predictors of tuberculosis-associated immune reconstitution inflammatory syndrome in HIV and tuberculosis coinfected persons in Thailand","volume":"25","author":"HV Tieu","year":"2009","journal-title":"AIDS research and human retroviruses"},{"issue":"5","key":"ref38","doi-asserted-by":"crossref","first-page":"e10527","DOI":"10.1371\/journal.pone.0010527","article-title":"Incident tuberculosis during antiretroviral therapy contributes to suboptimal immune reconstitution in a large urban HIV clinic in sub-Saharan Africa","volume":"5","author":"SM Hermans","year":"2010","journal-title":"PloS one"},{"issue":"1","key":"ref39","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1365-2249.2008.03725.x","article-title":"Regulatory T cells in human immunodeficiency virus-infected patients are elevated and independent of immunological and virological status, as well as initiation of highly active anti-retroviral therapy","volume":"154","author":"JC Gaardbo","year":"2008","journal-title":"Clinical and experimental immunology"},{"issue":"11","key":"ref40","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1093\/infdis\/jit368","article-title":"Early Immunologic Failure is Associated With Early Mortality Among Advanced HIV\u2013Infected Adults Initiating Antiretroviral Therapy With Active Tuberculosis","volume":"208","author":"S Ravimohan","year":"2013","journal-title":"The Journal of infectious diseases"},{"issue":"3","key":"ref41","doi-asserted-by":"crossref","first-page":"e0173309","DOI":"10.1371\/journal.pone.0173309","article-title":"Incidence and predictors of tuberculosis among HIV-infected adults after initiation of antiretroviral therapy in Nigeria, 2004\u20132012","volume":"12","author":"I Pathmanathan","year":"2017","journal-title":"PloS one"},{"key":"ref42","article-title":"Incidence and determinants of tuberculosis among adults initiating antiretroviral therapy\u2014Mozambique, 2004\u20132008","volume":"8","author":"AF Auld","year":"2013","journal-title":"PloS one"},{"issue":"4","key":"ref43","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/QAI.0b013e3181f9fb39","article-title":"Tuberculosis in patients receiving antiretroviral treatment: incidence, risk factors and prevention strategies","volume":"56","author":"A Van Rie","year":"2011","journal-title":"Journal of Acquired Immune Deficiency Syndromes (1999)"},{"key":"ref44","article-title":"Impact of Xpert MTB\/RIF on antiretroviral therapy-associated tuberculosis and mortality: a pragmatic randomized controlled trial","author":"L Mupfumi","year":"2014","journal-title":"Open Forum Infectious Diseases"},{"issue":"8","key":"ref45","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1056\/NEJMoa0907488","article-title":"An algorithm for tuberculosis screening and diagnosis in people with HIV","volume":"362","author":"KP Cain","year":"2010","journal-title":"The New England journal of medicine"},{"key":"ref46"},{"issue":"1","key":"ref47","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s12916-015-0320-9","article-title":"The predictive value of current haemoglobin levels for incident tuberculosis and\/or mortality during long-term antiretroviral therapy in South Africa: a cohort study","volume":"13","author":"AD Kerkhoff","year":"2015","journal-title":"BMC medicine"},{"issue":"11","key":"ref48","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.5588\/ijtld.14.0143","article-title":"Elevated hepcidin at HIV diagnosis is associated with incident tuberculosis in a retrospective cohort study","volume":"18","author":"PA Minchella","year":"2014","journal-title":"The international journal of tuberculosis and lung disease: the official journal of the International Union against Tuberculosis and Lung Disease"},{"issue":"1","key":"ref49","doi-asserted-by":"crossref","first-page":"e1000391","DOI":"10.1371\/journal.pmed.1000391","article-title":"Development of a standardized screening rule for tuberculosis in people living with HIV in resource-constrained settings: individual participant data meta-analysis of observational studies","volume":"8","author":"H Getahun","year":"2011","journal-title":"PLoS medicine"},{"issue":"11","key":"ref50","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1086\/522986","article-title":"Tuberculosis after initiation of antiretroviral therapy in low-income and high-income countries","volume":"45","author":"MW Brinkhof","year":"2007","journal-title":"Clinical infectious diseases: an official publication of the Infectious Diseases Society of America"},{"issue":"9944","key":"ref51","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/S0140-6736(14)60162-8","article-title":"Isoniazid plus antiretroviral therapy to prevent tuberculosis: a randomised double-blind, placebo-controlled trial","volume":"384","author":"MX Rangaka","year":"2014","journal-title":"Lancet"},{"issue":"8","key":"ref52","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1097\/QAD.0000000000001078","article-title":"Post-treatment effect of isoniazid preventive therapy on tuberculosis incidence in HIV-infected individuals on antiretroviral therapy","volume":"30","author":"T Sumner","year":"2016","journal-title":"AIDS"},{"issue":"3","key":"ref53","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/QAD.0000000000000535","article-title":"Tuberculosis incidence after 36 months\u2019 isoniazid prophylaxis in HIV-infected adults in Botswana: a posttrial observational analysis","volume":"29","author":"T Samandari","year":"2015","journal-title":"AIDS"},{"issue":"10","key":"ref54","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S1473-3099(13)70218-4","article-title":"Isoniazid prevention of HIV-associated tuberculosis","volume":"13","author":"MX Rangaka","journal-title":"The Lancet infectious diseases"},{"issue":"6","key":"ref55","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S1473-3099(13)70360-8","article-title":"Do high rates of empirical treatment undermine the potential effect of new diagnostic tests for tuberculosis in high-burden settings?","volume":"14","author":"G Theron","year":"2014","journal-title":"The Lancet infectious diseases"}],"updated-by":[{"DOI":"10.1371\/journal.pone.0198711","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000}}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0192030","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,24]],"date-time":"2018-10-24T00:47:10Z","timestamp":1540342030000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0192030"}},"subtitle":[],"editor":[{"given":"Ann","family":"Rawkins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,1,31]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,1,31]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0192030","relation":{"correction":[{"id-type":"doi","id":"10.1371\/journal.pone.0198711","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,31]]}}}